Welcome to our dedicated page for Terra Innovatum Global news (Ticker: NKLR), a resource for investors and traders seeking the latest updates and insights on Terra Innovatum Global stock.
Terra Innovatum Global N.V. (NASDAQ: NKLR) generates news as a developer of micro-modular nuclear reactors focused on its SOLO™ Micro-Modular Reactor platform. Company announcements frequently center on regulatory progress with the U.S. Nuclear Regulatory Commission (NRC), manufacturing partnerships, investor communications, and early-stage commercial agreements. For readers tracking developments in nuclear energy, data center infrastructure, and clean power solutions, NKLR news provides insight into how the SOLO concept is advancing toward deployment.
Recent press releases highlight Terra Innovatum’s expanded NRC engagement, including topical reports on reactor module design, core design using commercially available low-enriched uranium fuel, emergency planning zone analysis, first-of-a-kind siting, and defense-in-depth safety features. News items also cover the company’s outsourced manufacturing model, such as the agreement with ATB Riva Calzoni in Italy to establish SOLO manufacturing processes, assembly lines, and logistics for first-of-a-kind and commercial units.
Investors and industry observers can also follow NKLR news for updates on commercial activity. Terra Innovatum has reported non-binding MOUs and letters of intent, including a pilot program with Uvation Inc. to power AI-focused data centers with SOLO, as well as an identified deployment site in Illinois with potential for multiple SOLO units. Additional coverage includes participation in major nuclear and clean energy conferences and the company’s transition to trading on Nasdaq following a business combination.
This news feed brings together these disclosures so readers can monitor Terra Innovatum’s regulatory milestones, manufacturing readiness, conference participation, and commercial discussions around the SOLO micro-modular reactor.
Terra Innovatum (NASDAQ:NKLR) said the NRC advanced its draft Part 57 microreactor rulemaking on April 27, 2026, a framework the company says supports factory-built, transportable, modular reactors and standardized design approval for fleet deployment.
Terra highlighted alignment between the draft rule’s risk-informed, performance-based approach and its SOLO™ Micro-Modular Reactor design, and noted ongoing regulatory engagement including docketed topical reports and progress toward Construction Permit Application readiness.
Terra Innovatum (NASDAQ:NKLR) contracted Boldrocchi to supply a helium leak-tight circulator for SOLO™ experimental facilities, supporting closed-loop helium handling and controlled reactor testing.
This equipment aims to validate reactor and system performance under representative operating conditions, strengthening the technical foundation toward commercialization and deployment readiness.
Terra Innovatum (NASDAQ:NKLR) disclosed receipt of a Nasdaq Listing Delinquency Letter and an update on its Form 10-K for year ended December 31, 2025. The company is finalizing the filing under new CFO leadership and expects to file within the Nasdaq compliance period while working with auditors on technical accounting items.
The company reported a strong cash position of over $100 million as of December 31, 2025 and said the Nasdaq notice has no immediate effect on listing or trading.
Terra Innovatum (NASDAQ: NKLR) will host a Business Update on April 16, 2026 to review progress as it enters manufacturing execution for the SOLO Micro-Modular Reactor.
The company is finalizing its Form 10-K for fiscal 2025, expects to file in the near term, and will address the expected Nasdaq notification within the required timeframe.
Terra Innovatum (NASDAQ: NKLR) and Mersen announced successful production and validation of a nuclear‑grade graphite reactor core prototype to required tolerances, advancing manufacturing readiness for SOLO™ FOAK deployment targeted for 2027 and NOAK commercialization beginning in 2028.
The milestone confirms supply‑chain conversion into manufacturing execution and establishes procedures for repeatable, scalable production.
Terra Innovatum Global (NASDAQ: NKLR) announced an updated timeline for its Annual Report on Form 10-K and earnings call following the appointment of Kathy Williams as Chief Financial Officer. The company will file its Form 10-K on April 15, 2026 and host its earnings call on April 16, 2026.
Management said no changes are expected to the company’s previously communicated business outlook. The earnings call will include a Q&A and will be available via telephonic replay and webcast through April 30, 2026.
Terra Innovatum (NASDAQ: NKLR) appointed Kathy Williams as Chief Financial Officer and named Mike Howard as Chairman of the Board, supporting the company’s move toward Construction Permit Application readiness with the U.S. NRC.
Williams, previously Chairman, brings more than 40 years in the global nuclear sector; the company thanked former CFO Guillaume Moyen for his contributions.
Terra Innovatum (NASDAQ: NKLR) released an updated investor presentation ahead of the ROTH Conference highlighting progress toward an NRC Construction Permit, a completed SOLO™ reactor design, secured nuclear-grade supply chain, and early commercial traction.
Key specifics: ~200 non-binding pre-commercial unit commitments (~$4 billion potential), FOAK target in 2027, commercialization in 2028, and manufacturing pre-fabrication underway.
Terra Innovatum Global (NASDAQ: NKLR) will release audited fiscal year 2025 financial results before markets open on Wednesday, April 1, 2026. A conference call and webcast will be held at 8:00 a.m. ET featuring CEO Alessandro Petruzzi and CFO Guillaume Moyen.
The call will review results and provide updates on licensing, business development and corporate activities, followed by a Q&A. Live webcast and slide deck available via the company investor site; telephonic replay runs through April 15, 2026.
Terra Innovatum (NASDAQ: NKLR) executed a first procurement order for nuclear‑grade graphite with Mersen to support its SOLO™ First‑of‑a‑Kind (FOAK) reactor targeted for 2027 and enable NOAK serial commercialization beginning in 2028. The order follows completion of component supply‑chain alignment and initiates material optimization and joint R&D to support scalable manufacturing.
The collaboration establishes an industrial supply pathway and quality assurance workstreams intended to underpin deployment‑phase execution and longer‑term serial production readiness.